Clinical trial
Study of MRA in Patients With Rheumatoid Arthritis (RA)
NCT00144651 · Chugai Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00144651 |
|---|---|
| Title | Study of MRA in Patients With Rheumatoid Arthritis (RA) |
| Official title | An Open-label, Extension, Phase II Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Were Participated in Study MRA009JP |
| Lead sponsor | Chugai Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | MRA(Tocilizumab) |
| Enrollment | 135 |
| Start date | Aug 1, 2001 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 5, 2005 |
| Last update posted | Aug 9, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: